glp-1 inventor How Drugs Went From Lab Discovery to Weight-Loss Breakthroughs Tang Prize | Laureates |
Description
J., Gotz, A., Tschop, M
All we're proposing to clinicians is Hey, think about the patients who are at risk and have a strategy to monitor and mitigate that risk. What about patients on GLP-1s
A research study to look at How Semaglutide compared to placebo affects diabetic eye disease in people with type 2 diabetes (FOCUS)
Addressing this effect and further research to elucidate the causes are justified
Long-term use is determined by how well it fits each patient's needs
